phosphodiesterase 3A, cGMP-Inhibited (PDE3A) (N-Term) Peptide
-
- Target See all PDE3A products
- PDE3A (phosphodiesterase 3A, cGMP-Inhibited (PDE3A))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-PDE3A antibody (Catalog #: ARP44356_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- PDE3A (phosphodiesterase 3A, cGMP-Inhibited (PDE3A))
- Synonyms
- PDE3A Peptide, Pde3a Peptide, si:dkey-48h7.2 Peptide, A930022O17Rik Peptide, C87899 Peptide, RNPDE3A Peptide, CGI-PDE Peptide, CGI-PDE A Peptide, CGI-PDE-A Peptide, phosphodiesterase 3A Peptide, phosphodiesterase 3A, cGMP-inhibited Peptide, cGMP-inhibited 3',5'-cyclic phosphodiesterase A Peptide, phosphodiesterase 3A, cGMP inhibited Peptide, PDE3A Peptide, Pde3a Peptide, LOC100540515 Peptide, pde3a Peptide
- Background
-
PDE3A belongs to the cyclic nucleotide phosphodiesterase family. It hydrolyzes both cyclic AMP (cAMP) and cyclic GMP (cGMP).
Alias Symbols: CGI-PDE, CGI-PDE A, CGI-PDE-A
Protein Size: 1141 - Molecular Weight
- 125 kDa
- Gene ID
- 5139
- NCBI Accession
- NM_000921, NP_000912
- UniProt
- Q14432
-